Elucidating relevance of bilirubin-displacing effect of ceftriaxone in neonatal sepsis by determination of unbound "free" bilirubin

Pediatrics and Related Topics

Volumn 35, Issue 4, 1996, Pages 341-353

  Matthess, A ^a   Isenberg, H ^a   Gulian, J M ^b   Dalamasso, C ^b   Ruch, W ^c   Martin, E ^d   Wemmer, U ^a  

^a KLINIKUM DARMSTADT   (Germany)

^b AIX MARSEILLE UNIVERSITY   (France)

^c University Children's Hospital ^*  (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Bilirubin displacement; Ceftriaxone; Kernicterus; Neonate

Indexed keywords

ALBUMIN; BILIRUBIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INTRAVENOUS DRUG ADMINISTRATION; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SEPSIS; RISK FACTOR;

EID: 0030498079     PISSN: 0030932X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Silverman, W.A., D.H. Anderson, W.A. Blanc and D.N. Crozier: A difference in mortality rate and incidence of kernicterus among premature infants allocated to two prophylactic antibacterial regimens. Pediatrics. 18 (1956) 614-624.
2. Odell, G.B.: Studies in kernicterus. I. The protein binding of bilirubin. J. Clin. Invest. 38 (1959) 832-838.
3. Stern, L.: Drug interactions. Part II. Drugs, the newborn infant, and the binding of bilirubin to albumin. Pediatrics. 49 (1972) 916-918.
4. Wennberg, R.P., M. Lau and L.F. Rasmussen: Clinical significance of unbound bilirubin. Pediatr. Res., 10 (1976) 434
5. Wennberg, R.P and C.E. Ahlfors: Free bilirubin is of importance. Pediatrics. 70 (1982) 658-659.
6. Cashore, W.J. and W. Oh: Unbound Bilirubin and Kernicterus in low-birth-weight infants. Pediatrics. 69 (1982) 481-485.
7. Ritter, D.A., J.D. Keehy, H.J. Norton and A.J. Rudolph: A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics. 69 (1982) 260-266.
8. Brodersen, R.: Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr. Scand. 66 (1977) 625-634.
9. Brodersen, R.: Bilirubin solubility and interaction with albumin and phospholipid. J. Biol. Chem. 254 (1979) 2384-2390.
10. Brodersen, R and L. Stern: Deposition of bilirubin acid in the nervous system-A hypothesis for the development of kernicterus. Acta Paediatr. Scand 79 (1990) 12-19.
11. Perlman, M. and J.W. Frank: Bilirubin beyond the blood-brain barrier Pediatrics 81 (1988) 304-315.
12. Cashore, W.J.: The neurotoxicity of bilirubin. Clinics in Permatoloay. 17 (1990) 437-447.
13. Walker, P.C.: Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement. Clin Pharmacokinetics. 13 (1987) 26-50.
14. Ter Braak, E.W., P.J. De Vries, K.P. Bouter, S.G. Van der Vegt, G.C. Dorrestein, J.W. Nortier, A. Van Dijk, R.P. Verkooyen and H.A. Verbrugh: Once-daily dosing regimen for aminoglycosides plus β-lactam combination therapy of serious bacterial infections. Comparative trial with netilmicin plus ceftriaxone. Am. J. Med., 89 (1990) 58-66.
15. Martin, E., J.R. Koup, U. Paravicini and K. Stoeckel: Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr , 105 (1984) 475-481.
16. Schaad, U.B., W.L. Hayton and K. Stoeckel: Single dose ceftriaxone kinetics in the newborn. Clin. Pharmacol Therap., 37 (1985) 522-528.
17. Hayton, W.L and K. Stoeckel: Age-associated changes in ceftriaxone pharmacokinetics. Clin. Pharmacokinetics. 11 (1986) 76-86.
18. Gulian, J.M., C. Dalmasso, F. Pontier and V. Gonard: Displacement effect of ceftnaxone on bilirubin bound to human serum albumin. Chemotherapy. 32 (1986) 399-403.
19. Gulian, J.M., V. Gonard, C. Dalmasso and C. Palix: Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of "free" bilirubin and erythrocyte-bound bilirubin. J. Antimicrobial Chemotherapy. 19 (1987) 823-829.
20. Fink, S., W. Karp and A. Robertson: Ceftriaxone effect on bilirubin-albumin binding. Pediatrics. 80 (1987) 873-875.
21. Robertson, A., S. Fink and W. Karp: Effect of cephalosporins on bilirubin-albumm binding. J Pediatr., 112 (1988) 291-294.
22. Brodersen, R. and A. Robertson: Ceftriaxone binding to human serum albumin. Competition with bilirubin. Mol. Pharmacol. 36 (1989) 478-483.
23. Martin, E., S. Fanconi, P. Kalin, C. Zwingelstein, C. Crevoisier, W. Ruch and R. Brodersen: Ceftriaxone-bilirubin-albumin interactions in the neonate: an in vivo study. Eur. J. Pediatr., 152 (1993) 530-534.
24. Kim, M.H., J.J. Yoon, J. Sher and A.K. Brown: Lack of predictive indices in kernicterus. A comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics. 66 (1980) 852-858.
25. Jacobson, J and R.P. Wennberg: Determination of unbound bilirubin in the serum of newborns. Clin. Chem., 20 (1974) 783-789.
26. Wahlefeld, A.W., G. Herz and X. Bernt: Modification of the Malloy-Evelyn method for a simple determination of total bilirubin in serum. E J. Clin. Lab. Invest., 29 (1972) Suppl. 126, Abstract 11.12.
27. Doumas, B.T., W.A. Watson and H.G. Biggs: Albumin standards and measurement of serum albumin with bromcresol green. Clin. Chim Acta. 31 (1971) 87-96
28. Newman, T.B and M.J. Maisels: Evaluation and treatment of jaundice in the term newborn. A kinder, gentler approach. Pediatrics. 89 (1992) 809-818.
29. Harris, R.C., J.F. Lucey and J.R. MacLean: Kernicterus in premature infants associated with low concentrations of bilirubin concentration Pediatrics. 21 (1958) 875-884
30. Gartner, L.M., R.N. Snyder, R.S. Chabon and J. Bernstein: Kernicterus. High incidence in premature infants with low serum bilirubin concentrations. Pediatrics. 45 (1970) 906-917.
31. Lucey, J.F.: The unsolved problem of kernicterus in the susceptible low birth weight infant. Pediatrics. 45 (1972) 646-647.
32. Cashore, W.J and R. Brodersen: Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr. Scand. 72 (1983) 415-419.
33. Ebbesen, F. and A. Knudsen: The possible risk of bilirubin encephalopathy as predicted by plasma parameters in neonates with previous severe asphyxia. Eur J. Pediatr., 151 (1992) 910-912.
34. Levine, R.I., W.R. Fredericks and S.I- Rapoport: Entry of bilirubin into the brain due to opening of the blood-brain barrier. Pediatrics. 69 (1982) 255-259.
35. Funato, M., H. Tamai, S. Shimada and H. Nakamura: Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics. 93 (1994) 50-53.
36. Oie, S. and G Levy: Effect of salicyclic acid on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia. J. Pharm Sci., 68 (1979) 1-6.
37. Esbjörner, E., P. Larsson, P. Leissner and L. Wranne: The serum reserve albumin concentration for monoacetyldiamindiphenylsulphone and auditory evoked responses during neonatal hyperbilirubinemia. Acta Paediatr. Scand. 80 (1991) 406-412.